Cargando…
The Clinical Potential of Circulating Tumor Cells; The Need to Incorporate a Modern “Immunological Cocktail” in the Assay
The accepted clinical assay, CellSearch(®), and lab-on-a-chip tests for capturing circulating tumor cells are antibody-mediated. Attempts to improve their sensitivity have relied upon physical changes in the instruments. There have been no significant advances in improving the antibody-mediated port...
Autor principal: | Uhr, Jonathan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875962/ https://www.ncbi.nlm.nih.gov/pubmed/24351672 http://dx.doi.org/10.3390/cancers5041739 |
Ejemplares similares
-
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
por: Abedon, Stephen T., et al.
Publicado: (2021) -
Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications
por: Vicente, Manuel M., et al.
Publicado: (2023) -
Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells
por: Jeong, Keun-Yeong, et al.
Publicado: (2018) -
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018) -
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
por: Abedon, Stephen T., et al.
Publicado: (2021)